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Purpose: In the field of ophthalmology, the conjunctival
autograft is a useful therapeutic material in many cases, but
the small size of the autograft is a disadvantage. Therefore,
we evaluated the feasibility of taking an expanded sample of
conjunctival tissue using a subtenon's silicone implant.
Materials and Methods: We included a total of nine rabbits;
eight rabbits were operative cases, and one was a control. A
portion of conjunctival tissue from the control rabbit, which
did not undergo surgery, was dissected and examined to
determine whether it was histologically different from the
experimental group. The surgical procedure was performed on
eight rabbits via a subtenon's insertion of a silicone sponge
in the left superior-temporal portion; after surgery, we dropped
antibiotics into the eyes. We sacrificed a pair of rabbits every
three days (on days 3, 6, 9, and 12) after surgery, removed
the expanded conjunctival tissues with the silicone sponge
implants, and measured their sizes. Results: The mean size of
the expanded conjunctival tissues was 194.4 mm
2. On the third
day, we were able to harvest a 223.56 mm
2 section of
conjunctival tissue, which was the most expanded sample of
tissue in the study. On the twelfth day, we removed a 160.38
mm
2 section of conjunctival tissue, which was the least
expanded sample of tissue. Statistically, there were no
significant differences in the mean dimensions of the expanded
conjunctival tissues for each time period. Microscopic
examinations showed no histological differences between the
expanded conjunctival tissues and the normal conjunctival
tissues. Conclusion: The results reveal that this procedure is
a useful method to expand the conjunctiva for grafting and
transplantation.
Key Words: Conjunctival expansion, subtenon’s silicone
implant
INTRODUCTION
The conjunctiva is a thin, transparent mucosa
that forms the mucous layer of tears, is involved
in immune function, and functions to protect the
eye from foreign materials such as microor-
ganisms. The conjunctiva has many applications
as a treatment means in the diverse field of
ophthalmology. However, its utility is limited by
the quantity of the conjunctiva that can be
obtained. Therefore, we sought to take an
expanded sample of conjunctival tissue using the
subtenon's silicone implant.
We inserted a silicone sponge into one of the
rabbits’ eyes and determined whether the
conjunctival surface that was obtained after the
insertion varied over time by measuring the
surface of the autologous expanded conjunctiva.
If the surface varied, the time period when the
maximal conjunctiva surface could be obtained
was assessed. We also investigated whether the
expanded conjunctiva was different from the
normal conjunctiva upon histological examina-
tion.
MATERIALS AND METHODS
Subjects
Nine healthy, female New Zealand white
rabbits were purchased for this study. The rabbits
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were without abnormalities in the extraocular or
intraocular portions of the eye, the sizes of their
eyes were comparable, and they weighed an
average of 2 kg. Eight rabbits were divided into
four groups of two animals each. In the one rabbit
that did not undergo the silicone insertion
surgery, a portion of the conjunctival tissue was
dissected, stained, and examined to determine
whether it was histologically distinct from the
experimental groups.
Procedure
We considered the Association for Research in
Vision and Ophthalmology (ARVO) statement on
the use of animals in ophthalmic and vision
research. When we planned this project, we
assumed that our bilateral ocular surgeries had
the potential to affect vision bilaterally. Therefore,
we performed a monocular procedure.
The systemic anesthetic agent ketamine chloride
(50 mg/mL), 40 mg/kg, and the sedative Xylazine
HCl (23.3 mg/mL), 23.3 mg/kg, were injected into
the back muscles of the rabbits, and the rabbits
were anesthetized.
Before the procedure, the area around the eye
was sterilized with Betadine to prevent infection.
Infraduction and adduction of the left eyeball of
each of the eight rabbits was performed, the
superior-temporal bulbar conjunctiva area was
exposed maximally, and in an area 1 mm away
from the corneal limbus, the superior-temporal
conjunctiva and the Tenon's capsule were dissected
carefully with a pair of spring scissors under a
surgical microscope. For the cases in which
infraduction and adduction were not performed
sufficiently and the surgery was difficult, bridle
suture suspension was performed with 10 - 0 nylon
at the 12 o’clock position of the cornea, and the
surgery was subsequently performed. An oval
silicone sponge 5.0 mm × 15.0 mm × 3 mm in size
was inserted into the inferior part of the dissected
conjunctiva and the Tenon’s capsule and fixated
to the sclera using 5- 0 Ethibond suture. Afterward,
the previously- dissected conjunctiva and Tenon’s
capsule were sutured with 7 - 0 Vicryl suture (Fig.
1).
After the surgery, ofloxacin ointment was
applied to prevent infection, and ofloxacin drops
were administered to the left eye four times per
day.
Outcome measures
Four groups of rabbits consisting of two
animals each were sacrificed sequentially on the
3rd, 6th, 9th, and 12th day after surgery, then we
marked the borders of the conjunctival tissues on
the top of the silicone sponge with 7 - 0 Vicryl
suture and performed the dissection of the
conjunctiva by injecting saline into the subcon-
junctival area. Conjunctival tissues and a portion
of Tenon’s capsule tissue were dissected together.
The harvested tissues were placed on a glass plate
installed on the top of a grid scale ruler on which
the scale of one grid is 1.8 mm, and the surface
was measured. The sizes of the conjunctivae
obtained from each group were compared, and
the time when the maximum conjunctival tissue
could be obtained was determined. The con-
junctivae from each experimental group were
examined under a light microscope after staining.
The width and length of the silicone sponges were
5 mm and 15 mm, respectively. Therefore, we
regarded the control as a 5 × 15 mm conjunctival
area. In the one rabbit that did not undergo the
silicone insertion surgery, a portion of the
conjunctival tissue was dissected, stained, and
examined to determine whether it was histolo-
gically distinct from the that of the experimental
groups.
Fig. 1. Insertion of a silicone sponge, and suture of the
conjunctiva and Tenon’s capsule.Conjunctival Expansion using a Subtenon's Silicone Implant in New Zealand White Rabbits
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RESULTS
Conjunctival tissues were obtained from eight
rabbits after the silicone sponge insertion was
performed.
In our study, during the period of time from the
insertion of the silicone sponge until the
conjunctival tissues were obtained, none of rabbits
developed impairment of eye movement, lago-
phthalmos, or conjunctival symblepharon. The
eight rabbits were divided into four groups with
three-day intervals until their sacrifice after
surgery. The areas of the conjunctivae obtained
from all eight eyes are shown in Table 1, Fig. 2.
The mean width of the conjunctival tissues
obtained from the eyes of the eight rabbits was 9.0
± 1.36 mm, and the mean length was 21.6 ± 1.66
mm. The average surface area of the conjunctival
tissues of all eight eyes was 194.4 ± 33.08 mm
2.
Table 1 shows the average surface of the conjunctiva
within each of the four groups.
The rabbits from which the largest conjunctival
area was obtained were in the group that had the
conjunctiva dissected three days after surgery,
and the mean area was 223.56 mm
2 (a 298.1%
expansion). The group from which the smallest
area was obtained was from the rabbits in which
12 days had passed from the time of the insertion
surgery to the dissection of the conjunctiva, and
the mean area was 160.38 mm
2 (a 213.8% expan-
sion).
The width, length, and mean area of the
conjunctival tissues within each group of rabbits
divided according to the sacrifice time were not
statistically significantly different (p > 0.05) when
analyzed using the Kruskall-Wallis test.
In one of the rabbits where 12 days had elapsed
after the insertion procedure, a local scarring
occurred in the conjunctiva (Fig. 3), and thus
during the surgery performed to obtain the
conjunctival tissue, a small buttonhole was gene-
rated in the end area of the conjunctival tissues.
Upon histological examination of this case, we
found many capillaries and fibrosis (Fig. 4).
Conjunctivitis also developed in the eye of one
rabbit 12 days after the insertion procedure, and
Table 1. The Area of the Conjunctival Tissue Obtained from Each Rabbit
Rabbit number 1 2 3 4 5 6 7 8
Width of control (mm) 5 5 5 5 5 5 5 5
Width (mm) 10.8 9.0 9.0 9.0 10.8 7.2 9.0 7.2
Expanded width rate (%) 216 180 180 180 216 144 180 144
Length of control (mm) 15 15 15 15 15 15 15 15
Length (mm) 23.4 21.6 21.6 23.4 19.8 23.4 19.8 19.8
Expanded length rate (%) 156 144 144 156 132 156 132 132
Dimensions of control (mm
2) 75 75 75 75 75 75 75 75
Dimensions (mm
2) 252.72 194.40 194.40 210.60 213.84 168.48 178.20 142.56
Expanded dimensions rate (%) 337.0 259.2 259.2 280.8 285.1 224.6 237.6 190.1
Post operative date (days) 3 6 9 12
Mean average of dimensions (mm
2) 223.56 202.5 191.16 160.38
Fig. 2. The dimensions of the conjunctival tissue obtained
from each rabbit.Ie-na Yoon, et al.
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we found that the conjunctival vessels were dilated.
On histological examination, comparable his-
tological findings among each group were found
(Fig. 5). In comparison with the control eye in
which the procedure was not performed (Fig. 6),
noticeable histological differences were not seen
with the exception of the case with conjunctival
scarring.
Fig. 3. One case developed local scarring in the conjunctiva. Fig. 4. Histological findings of the conjunctival scarring
(Hematoxylin-Eosin (HE) staining, × 200).
Fig. 5. Histological findings of the conjunctiva after the procedure. (Hematoxylin-Eosin (HE) staining, × 200). (A: Three days
after the procedure B: Six days after the procedure C: Nine days after the procedure D: Twelve days after the procedure)
A B
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DISCUSSION
In the field of ophthalmology, the autologous
conjunctiva is very useful as a treatment means.
It can be used to treat persistent ulcerative
keratitis that has been unresponsive to drugs,
1
keratolysis of herpes keratouveitis,
2 neurotrophic
ulcers,
3 peripheral corneal ulcers, exposure
keratopathy, bullous keratopathy, chemical burns,
descemetocele, anophthalmos,
4-10 and for other
various reconstruction surgeries,
11,12 pterygium
surgeries.
13-18
Pterygium is a common disease. From the
conjunctiva to the cornea, triangle-shaped fibrova-
scular tissues proliferate in the bulbar conjunctiva
and invade the nasal cornea. The postsurgical
recurrence rate of pterygium is high, and a
recurrence rate of approximately 25 - 45% has
been reported.
19-20 Surgery for recurrant pterygium
cases requires the resection of the conjunctiva in
a wide area, and if the area beneath the sclera is
not covered by the conjunctiva after the recurrent
pterygium surgery, necrotizing scleritis may
develop. Visual acuity may also be lost in the
worst cases, and thus a large quantity of the
conjunctiva may need to be resected. Kenyon et
al.
21 reported a low recurrence rate in pterygium
surgery by using conjunctival autograft trans-
plantation, and subsequently this has become an
important surgery method in pterygium
treatment. This surgery is used primarily as a
treatment for recurrent pterygium, and it is
commonly performed in patients in their 20’s and
early 30’s in whom it readily recurs.
16,22 The
recurrence rate of pterygium after conjunctival
autograft transplantation has been reported to be
relatively low, from 5.3 - 14% depending on the
investigators, and it is also esthetically appropriate.
Therefore, it is a surgical method that has been
performed commonly depending on the sur-
geons.
16,23 Conjunctival autograft transplantation
has a great advantage in that it can reduce the
recurrence rate without the use of Mitomycin C.
22,24
The conjunctiva can be used in diverse cases,
but the limiting problem is the quantity that can
be obtained. In pediatric cases, the elasticity of the
conjunctiva is excellent, and thus a certain amount
of extra conjunctiva can be obtained, but as
patients age this elasticity is decreased. In elderly
patients requiring a large area of the conjunctiva
for transplantation, a sufficient amount of the
mucosa can not be obtained in many cases.
Recently, amniotic membranes have been used
in place of the conjunctiva in many cases,
25-40 and
for the reconstruction of the conjunctival surface
in pterygium, conjunctival intraepithelial neoplasia,
conjunctival scarring, conjunctival symblepharon,
or conjunctivochalasia cases with large defects in
the area of the conjunctiva, amniotic membrane
transplantation has been performed. However, in
such cases it is necessary to consider that amniotic
membrane is expensive, its storage is complex, and
amniotic membranes may be infected. Additionally,
after transplantation, the grafted amniotic mem-
brane can be torn relatively easily and detached
again, and the mucus secreted from the mucosa is
not sufficient for lubrication, so postoperative dry
eye syndrome may also develop. Furthermore,
although it is rare, cases of cornea melt after amniotic
membrane transplantation have been reported.
41 In
contrast, conjunctival autograft transplantation has
the advantages that it is inexpensive in comparison
with that using amniotic membrane, its outcome is
good esthetically, complications are almost absent,
and the risk of infection is markedly lower.
Therefore, if more conjunctival autografts could be
obtained, they would be widely used in clinics.
We attempted to obtain an increased amount of
the conjunctiva by inserting a silicone sponge into
the subtenon space of rabbits and thus inducing
conjunctival expansion. The silicone sponge for
human eyes was relatively large for the rabbits’
Fig. 6. Histological findings of the normal conjunctiva
(Hematoxylin-Eosin (HE) staining, × 200).Ie-na Yoon, et al.
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eyes, but none of the rabbits developed
lagophthalmos after the procedure in our study.
Therefore, we conclude that in humans, whose
eyeballs are bigger than those of rabbits, the
insertion of a silicone sponge may be useful in
obtaining a certain amount of conjunctival tissues
without developing lagophthalmos.
To obtain useful conjunctival tissue, it is
imperative not to make a buttonhole in the tissue.
It is important not to pull the conjunctival tissues
excessively with a forceps or manipulate a pair of
spring scissors carelessly during the dissection.
Above all, care must be taken to prevent the
formation of adhesions, scars or granulomas. In
our study, a scar developed locally in the
conjunctiva of one eye, meaning that during the
procedure to obtain conjunctival tissue a small
buttonhole was made in the end area of the
scarred conjunctival tissue. Clearly, during the
insertion of the silicone sponge into the subtenon
space, injuries to the tissue can be minimized by
paying close attention to the manipulation. The
surgeon has to be careful during the insertion of
the silicone sponge and the resection of the
conjunctival tissues, not only to minimize the
formation of buttonholes in the conjunctiva, but
also because the insertion of the silicone material
itself can induce inflammatory reactions.
42
Consequently, inflammatory changes can develop
in the conjunctiva, conjunctival hyperemia can
persist, a thick conjunctival scar can form, and by
developing a severe adhesion to other adjacent
tissues, diplopia may develop, as well as other
postoperative complications. When additional
conjunctival tissues are required in the future,
such changes render it difficult to obtain a
satisfactory amount of conjunctival tissue. To
prevent the development of such results, the
tissue has to be manipulated carefully while
performing the procedure to minimize damage. It
is possible that subconjunctival injection of
steroids and other anti-inflammatory agents may
be helpful, and useful results may be obtained
from studies that compare the group receiving
injected anti-inflammatory agents into the sub-
conjunctival after the completion of surgery with
a group not receiving any injections.
The conjunctival tissue obtained 12 days after
the procedure was not only the smallest, but it
was also found that buttonholes, conjunctivitis,
conjunctival vessel dilation, and other complica-
tions had developed simultaneously. On the basis
of such results, we conclude that leaving a silicone
sponge in the eye for a long time is not desirable.
However, the sample size in our study was small,
and thus it was difficult to consider the results to
be statistically significant. Inter-animal variability
of response and size of the eyes may also have
influenced our results. Studies on larger samples
are required in the future.
In our study, during the period of time from the
insertion of the silicone sponge until the con-
junctival tissues were harvested, none of the cases
developed an impairment of eyeball movement
and conjunctival symblepharon. Because the rabbits
were sacrificed immediately before obtaining the
conjunctival tissues, we could not examine whether
conjunctival symblepharon or other inflammatory
changes developed after harvesting the conjunctival
tissues. In the future, studies that obtain the
conjunctival tissues without sacrificing the rabbits
and that subsequently examine whether inflam-
matory changes such as conjunctival symblepharon
or impairment of eyeball movement occur should
be developed and should include a follow-up
observation period.
In our study, one of the most important
procedures was measuring the area of the
conjunctiva on the top of the glass plates. In order
to minimize the development of buttonholes
while obtaining the conjunctival tissue, a resection
including a part of Tenon’s capsule was made.
However, this may have introduced a measure-
ment error compared to a situation in which only
conjunctival tissue was harvested. Lee et al.
17
reported that in cases that developed necrotic
scleral lesions, if the lesions were covered with the
simple conjunctiva as well as Tenon’s capsule,
external stimulations to the necrotic area were
reduced. Additionally, because of the supply of
nutrients through blood vessels in the covered
conjunctiva, the pathological lesions were stabi-
lized and symptoms improved. Nevertheless, it is
thought that the in vivo application of this
technique to patients in the clinic is not necessary
except in special situations. Clinically, most
physicians use the conjunctiva alone without
Tenon’s capsule as grafting material.Conjunctival Expansion using a Subtenon's Silicone Implant in New Zealand White Rabbits
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With our procedure, a certain quantity of
conjunctival tissue was obtained without severe
complications. Therefore, we conclude that our
method may be useful in obtaining conjunctival
tissues in other settings such as clinics. Addi-
tionally, studies suggest that another method
7
used in congenital anophthalmos patients may be
useful to obtain conjunctival tissues. This method
involves inserting an ocular prosthesis into the
orbit of the patient, and a self-inflating hydrogel
expander is also inserted into the subconjunctival
space to expand the conjunctiva. Patients are
observed for 2-4 weeks before tissues are obtained.
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